buprenorphine

Manufacturer: PAYLESS COMPOUNDERS, LLC
Effective date: 2024-12-11
Label type: ANIMAL COMPOUNDED DRUG LABEL
Version: 10
Source: full-release
Hydrated at: 2026-06-01 02:51:18

Label at a glance#

Productbuprenorphine

Active ingredientBUPRENORPHINE HYDROCHLORIDE

Label structure4 sections

Label contents#

Full prescribing information#

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
238129	buprenorphine HCl 0.3 MG in 1 ML Injection	PSN	10
238129	1 ML buprenorphine 0.3 MG/ML Injection	SCD	10
238129	buprenorphine 0.3 MG/ML (as buprenorphine HCl 0.324 MG/ML) Injection	SY	10
238129	buprenorphine HCl 0.3 MG per 1 ML Injection	SY	10

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
BUPRENORPHINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
68654759-f50b-79ef-24c5-544d94fe7d87	Product name	3	20251114
08a295bb-88df-4ab0-a120-a75a789a74f1	Product name	1	20231013
cb89b86a-369e-4204-8910-ae797c503af3	Product name	1	20230706
ab841ac7-728a-4fc9-be0a-35b96cecbf39	Product name	4	20230306
100316cc-94a9-474e-97ad-9b5c6ddec605	Product name	5	20230125
539bc5d3-546b-4af6-9c31-058ce6c459d3	Product name	2	20220210
b871fccd-1de6-4c7f-b9e5-045304641ee6	Product name	8	20220118
d4880ace-a516-8c47-8dfd-73a4ba5887d7	Product name	2	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
31e16ab2-c562-4617-a3e8-ed285320e16e	Product name	1	20180201
4c23a34c-e8fc-424c-8fa0-ee064ba6eaef	Product name	1	20170706
a5920611-4285-f024-69b9-39ff338b81ea	Product name	5	20170609
3df867ed-9d48-45cf-bded-1394beaea0b1	Product name	3	20161206
973da5bf-b1f9-4de0-81ee-7ca066c98ca4	Product name	1	20160712
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
70022-001-10	buprenorphine	10 mL in 1 VIAL, MULTI-DOSE	INJECTION, SOLUTION	10	10
70022-004-10	buprenorphine	10 mL in 1 VIAL, MULTI-DOSE	SOLUTION	10	10
70022-010-03	buprenorphine	30 mL in 1 BOTTLE, PLASTIC	SOLUTION	30	10
70022-010-10	buprenorphine	100 mL in 1 BOTTLE, PLASTIC	SOLUTION	100	10

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
70022-001	BUPRENORPHINE INJECTION, SOLUTION BUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]	10	1 package rows	20241213_a1c1f498-e101-467f-b81c-1451c44e7a01.zip
70022-004	BUPRENORPHINE INJECTION, SOLUTION BUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]	10	1 package rows	20241213_a1c1f498-e101-467f-b81c-1451c44e7a01.zip
70022-010	BUPRENORPHINE INJECTION, SOLUTION BUPRENORPHINE SOLUTION [PAYLESS COMPOUNDERS, LLC]	10	2 package rows	20241213_a1c1f498-e101-467f-b81c-1451c44e7a01.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
38779-0888-0	GM - Gram	38779-0888	ea475beb-91f1-4bce-ba3e-3ec1b988f3f9	1	2014-09-03
38779-0888-1	GM - Gram	38779-0888	3fd81d18-9e25-45de-8c87-ee5e50fce5a8	1	2014-09-03
38779-0888-3	GM - Gram	38779-0888	42cd3e9d-3565-4121-972d-4b8020e22216	1	2014-09-03
38779-0888-6	GM - Gram	38779-0888	356a495c-16ae-4ea4-8c6c-20d53148d9b4	1	2014-09-03
38779-0888-9	GM - Gram	38779-0888	5b7015c7-96d3-4be2-bb53-082d7a263986	1	2014-09-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
BUPRENORPHINE HYDROCHLORIDE	ACTIVE INGREDIENT	56W8MW3EN1	1
BUPRENORPHINE	ACTIVE MOIETY	40D3SCR4GZ	1
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	1
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

buprenorphine
BUPRENORPHINE HYDROCHLORIDE
ANHYDROUS DEXTROSE
MANNITOL
WATER
HYDROCHLORIC ACID
BENZYL ALCOHOL
METHYLPARABEN
PROPYLPARABEN
SUCROSE
SODIUM BENZOATE
ANHYDROUS CITRIC ACID
SODIUM CITRATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
70022-001	70022-001-10
38779-0888
70022-004	70022-004-10
70022-010	70022-010-03, 70022-010-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BUPRENORPHINE HYDROCHLORIDE	56W8MW3EN1	ACTIM
ANHYDROUS DEXTROSE	5SL0G7R0OK	IACT
MANNITOL	3OWL53L36A	IACT
WATER	059QF0KO0R	IACT
HYDROCHLORIC ACID	QTT17582CB	IACT
BENZYL ALCOHOL	LKG8494WBH	IACT
BUPRENORPHINE HYDROCHLORIDE	56W8MW3EN1	ACTIM
WATER	059QF0KO0R	IACT
ANHYDROUS DEXTROSE	5SL0G7R0OK	IACT
HYDROCHLORIC ACID	QTT17582CB	IACT
BENZYL ALCOHOL	LKG8494WBH	IACT
MANNITOL	3OWL53L36A	IACT
BUPRENORPHINE HYDROCHLORIDE	56W8MW3EN1	ACTIM
METHYLPARABEN	A2I8C7HI9T	IACT
PROPYLPARABEN	Z8IX2SC1OH	IACT
WATER	059QF0KO0R	IACT
SUCROSE	C151H8M554	IACT
SODIUM BENZOATE	OJ245FE5EU	IACT
ANHYDROUS CITRIC ACID	XF417D3PSL	IACT
SODIUM CITRATE	1Q73Q2JULR	IACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 5 · 291 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / ORAL		388 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	CAPSULE / ORAL		7 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	LIQUID / ORAL		162 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SOLUTION / INTRAVENOUS	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SHAMPOO, SUSPENSION / TOPICAL	0.15 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION / INFILTRATION	0.35 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SPONGE / TOPICAL	NA		Exact identifier — unii candidate 35 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SUSPENSION / ORAL		320 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	FILM / BUCCAL	0.22 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / INTRAVENOUS		95 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION, SOLUTION / EPIDURAL		30 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	TABLET, EXTENDED RELEASE / ORAL	0.17 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUPPOSITORY / RECTAL	NA		Exact identifier — unii candidate 48 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	ENEMA / RECTAL	0.18 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION, SOLUTION / INTRAVENOUS		45 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / NASAL	140 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	INJECTION, EMULSION / INTRAVENOUS	0.1 %w/v		Exact identifier — unii candidate 35 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / RECTAL	35.42 %w/v		Exact identifier — unii candidate 48 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUSPENSION/ DROPS / OPHTHALMIC	0.01 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CREAM / VAGINAL		3 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	SPRAY / TOPICAL	0.01 %w/w		Exact identifier — unii candidate 61 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	INJECTION / INTRAVENOUS		864 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	TABLET / ORAL	1.8 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	GEL / TOPICAL		3 mg	Exact identifier — unii candidate 61 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / INFILTRATION		80 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	EMULSION / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	ENEMA / RECTAL	0.02 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	TABLET, COATED / ORAL	0.8 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	LOTION / TOPICAL		140 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	CAPSULE, EXTENDED RELEASE / ORAL	0.22 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	TABLET / ORAL	30 mg		Exact identifier — unii candidate 35 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION / INTRAMUSCULAR		6 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	POWDER, FOR SOLUTION / ORAL		123 mg	Exact identifier — unii candidate 61 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	GEL / DENTAL	0.08 %w/w		Exact identifier — unii candidate 35 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		414 mg	Exact identifier — unii candidate 61 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SOLUTION / TOPICAL	0.1 %w/v		Exact identifier — unii candidate 35 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	CONCENTRATE / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 61 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	OINTMENT / OPHTHALMIC	0.01 %w/w		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / PARENTERAL		18 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS	900 mg		Exact identifier — unii candidate 48 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	AEROSOL / TOPICAL	0.08 %w/w		Exact identifier — unii candidate 61 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS		1 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	SYRUP / ORAL		80 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION/ DROPS / OPHTHALMIC	0.05 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	POWDER, FOR SOLUTION / ORAL		13 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	ELIXIR / ORAL	5.02 mg/5ml		Exact identifier — unii candidate 35 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	FILM, SOLUBLE / BUCCAL		3 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	INJECTION, SUSPENSION / SUBCUTANEOUS	0.02 %w/v		Exact identifier — unii candidate 68 equally ranked IID candidates
SODIUM BENZOATE	SODIUM BENZOATE	OJ245FE5EU	GEL / RECTAL		406 mg	Exact identifier — unii candidate 35 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	FILM, SOLUBLE / BUCCAL		1 mg	Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	SOLUTION, CONCENTRATE / ORAL	1 mg/1ml		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 68 equally ranked IID candidates
ANHYDROUS CITRIC ACID	ANHYDROUS CITRIC ACID	XF417D3PSL	LIQUID / INTRAVENOUS		18 mg	Exact identifier — unii candidate 61 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	15 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii candidate 48 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	DROPS / ORAL	1 mg/1ml		Exact identifier — unii candidate 79 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	SOLUTION / ORAL	100 mg		Exact identifier — unii candidate 68 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	INJECTION / PERIDURAL	1 mg		Exact identifier — unii candidate 79 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 36 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
buprenorphine hydrochloride	BUPRENORPHINE HYDROCHLORIDE	Advagen Pharma Ltd	699638dd-3a53-445f-a545-d0e6eabfe1c9	2026-07-17	Warnings, Adverse reactions	Name fallback generic name: BUPRENORPHINE HYDROCHLORIDE
Buprenorphine	BUPRENORPHINE	REMEDYREPACK INC.	aa86a438-1ebf-4c08-bf27-38f1e81efb3a	2026-07-07	Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
buprenorphine hydrochloride	BUPRENORPHINE HYDROCHLORIDE	REMEDYREPACK INC.	11686845-f5fd-4e96-8a4f-9b132bf48840	2026-07-07	Warnings, Adverse reactions	Name fallback generic name: BUPRENORPHINE HYDROCHLORIDE
BUPRENORPHINE	BUPRENORPHINE	Unit Dose Solutions, Inc.	5578cd5c-c860-6e8a-e063-6394a90a56c7	2026-06-30	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
BUPRENORPHINE	BUPRENORPHINE	Bryant Ranch Prepack	aa132031-9d12-45b4-81e0-4a5877661379	2026-06-29	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
Buprenorphine	BUPRENORPHINE	Bryant Ranch Prepack	655e3e52-03be-496c-978a-5cffc74b2ae4	2026-06-29	Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
BUPRENORPHINE	BUPRENORPHINE	Unit Dose Solutions, Inc.	5479b218-a388-2c3c-e063-6294a90a0e85	2026-06-17	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
BUPRENORPHINE	BUPRENORPHINE	Bryant Ranch Prepack	966adb01-71b4-4e0b-bbc6-b83da9987aa2	2026-06-16	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
Buprenorphine	BUPRENORPHINE	Major Pharmaceuticals	dba586f9-e3f2-4b9c-849b-907c81a5a0ef	2026-06-16	Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
BUPRENORPHINE	BUPRENORPHINE	Bryant Ranch Prepack	bc5a7137-9e8f-438e-84d9-bdbf1db12998	2026-06-03	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
Buprenorphine	BUPRENORPHINE	Rhodes Pharmaceuticals LLC	2738feae-316e-426f-971c-5f142ac01b60	2026-05-29	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
Buprenorphine	BUPRENORPHINE	Actavis Pharma, Inc.	03819118-86f6-4329-adaf-4599e7b71f46	2026-05-25	Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
Buprenorphine	BUPRENORPHINE	Teva Pharmaceuticals USA, Inc.	36995ce3-b515-447b-baa9-aa14f84060d8	2026-05-12	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
BUPRENORPHINE	BUPRENORPHINE	Rhodes Pharmaceuticals LLC	da90618a-5621-4b15-bc48-9dcc631418de	2026-05-04	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
Buprenorphine	BUPRENORPHINE	INGENUS PHARMACEUTICALS, LLC	186e3be6-8bc0-4bb9-96f5-429d53632f45	2026-04-28	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
Buprenorphine	BUPRENORPHINE	Aveva Drug Delivery Systems Inc.	1aae9b13-7431-42ef-8558-14a2325820e6	2026-04-28	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
BUPRENORPHINE	BUPRENORPHINE	Bryant Ranch Prepack	cd0a90c6-32cc-4114-8573-86ac85503bdf	2026-04-03	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE
buprenorphine hydrochloride	BUPRENORPHINE HYDROCHLORIDE	PAI Holdings, LLC dba PAI Pharma	442831cf-9636-433a-9a12-e9a8cd31f72a	2026-02-28	Warnings, Adverse reactions	Name fallback generic name: BUPRENORPHINE HYDROCHLORIDE
Buprenorphine	BUPRENORPHINE	Sun Pharmaceutical Industries, Inc.	9fd1f18f-0b0f-4059-b603-19ecbf0ed63a	2026-02-11	Warnings, Adverse reactions	Name fallback brand name: Buprenorphine
BUPRENORPHINE	BUPRENORPHINE	A-S Medication Solutions	bfb02ea5-22f2-432e-afc8-f1dbe2ea0614	2026-02-06	Warnings, Adverse reactions	Name fallback brand name: BUPRENORPHINE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.